Markets:

Overview

News

Currencies

International

Treasuries

Iovance Biotherapeutics, Inc. - Common Stock (NQ:IOVA)

3.864 -0.016 (-0.41%)

Streaming Delayed Price Updated: 1:43 PM EDT, Jun 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Iovance Biotherapeutics, Inc. - Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

23 24 Next >

Iovance Biotherapeutics Shares Fell Today: What's Going On? ↗

February 10, 2025

Iovance Biotherapeutics Inc. (NASDAQ: IOVA) shares closed lower on Monday potentially following the company's announcement of Dan Kirby as Chief Commercial Officer.

Via Benzinga

Iovance Biotherapeutics Appoints Dan Kirby as Chief Commercial Officer

February 10, 2025

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Where Will Iovance Biotherapeutics Be in 5 Years? ↗

January 29, 2025

Via The Motley Fool

Meet the Growth Stock That Could Soar 280%, According to Wall Street Analysts ↗

January 27, 2025

Via The Motley Fool

3 Stocks That Could Turn $1,000 Into $5,000 by 2030 ↗

January 18, 2025

A handful of bullish factors are converging at the right time in the right way for all three of these companies.

Via The Motley Fool

Prediction: This Stock Will Beat the Market in 2025 ↗

December 12, 2024

Via The Motley Fool

Peering Into Iovance Biotherapeutics's Recent Short Interest ↗

December 05, 2024

Via Benzinga

Is Iovance Biotherapeutics Stock a Millionaire Maker? ↗

November 27, 2024

Via The Motley Fool

Earnings Scheduled For February 27, 2025 ↗

February 27, 2025

Via Benzinga

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

February 21, 2025

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

My 3 Favorite Stocks to Buy Right Now ↗

February 20, 2025

The market's underestimating how well each of these companies should be able to capitalize on their opportunities.

Via The Motley Fool

Iovance Biotherapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates on February 27, 2025

February 18, 2025

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

February 12, 2025

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

What's Wrong With Iovance Biotherapeutics Stock? ↗

January 30, 2025

Via The Motley Fool

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

January 17, 2025

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Iovance Biotherapeutics Shares Are Falling Today: What's Going On? ↗

January 10, 2025

Shares of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) are trading lower Friday. The company announced the inducement stock option grants under Nasdaq Listing Rule 5635(c)(4).

Via Benzinga

3 Mid-Cap Stocks That Could Take Off in 2025 ↗

January 09, 2025

Via The Motley Fool

Why Iovance Biotherapeutics Stock Zoomed More Than 5% Higher Today ↗

January 02, 2025

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session ↗

December 26, 2024

Via Benzinga

Got $1,500? Buy Iovance Biotherapeutics Now and Don't Look Back ↗

November 23, 2024

Via The Motley Fool

A Peek at Iovance Biotherapeutics's Future Earnings ↗

November 06, 2024

Via Benzinga

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

December 20, 2024

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

If I Could Only Buy 3 Stocks in the Last Month of 2024, I'd Pick These ↗

December 19, 2024

These windows of opportunity aren't likely to remain open for much longer.

Via The Motley Fool

2 Growth Stocks That Could Rocket Higher in 2025: Are They Right for Your Portfolio? ↗

December 17, 2024

Via The Motley Fool

3 Monster Stocks to Hold for the Next 10 Years ↗

December 07, 2024

Just be ready to ride out some inevitable turbulence along the way.

Via The Motley Fool

Iovance Biotherapeutics Announces the Promotion of Raj Puri, M.D., Ph.D. to Chief Regulatory Officer

November 26, 2024

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

BridgeBio Pharma, Rigetti Computing, Bath & Body Works And Other Big Stocks Moving Higher On Monday ↗

November 25, 2024

Via Benzinga

2 Innovative Stocks That Could Deliver Outsize Returns ↗

November 22, 2024

Via The Motley Fool

2 Top Biotech Stocks to Buy Now and Hold For 5 Years or More ↗

November 16, 2024

Via The Motley Fool

Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Third Quarter and Year to Date 2024

November 07, 2024

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

23 24 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.